Please login to the form below

Not currently logged in
Email:
Password:

Fishawack acquires brand communications agency Healthcircle

The agency will work alongside Fishawack’s medical communication businesses

The Fishawack Group is strengthening its creative services by adding brand communications agency Healthcircle to its offering.

Healthcircle is headquartered in London, UK and is known for its direct-to-patient communications approach, offering digital solutions and medical communications strategies.

Fishawack

Top row: Dominic Miller, Fishawack COO, Gail Flockhart, Fishawack Managing Director, Liz Maclaren, Healthcircle Creative Director, Dr. David Ingram, Healthcircle Managing Partner; Front row: Mike Taylor, Healthcircle Managing Director, Oliver Dennis, Fishawack CEO

The group is a network of medical communications and marketing organisation companies and has a portfolio of pharma and healthcare clients including Roche, Swiss pharma group Helsinn and phytomedicines company Schwabe Pharma Group.

Healthcircle has also worked on a variety of campaigns in the areas of oncology, idiopathic pulmonary fibrosis and consumer health to name a few.

It already operates globally, but joining Fishawack will allow the group to accelerate growth in the US while bolstering resources.

Mike Taylor, managing director of Healthcircle, said: “We’ve been on the lookout for a partner to support our growth in the US while also providing us access to scientific and strategic talent.”

Healthcircle is familiar with its new parent company however, after it previously worked with the Carling team - an agency serving the pharmaceutical, biotechnology and medical device industries - that Fishawack acquired in July last year.

Fishawack also operates under four other brands, including Medical communications groups Fishawack Communications and Fishawack Facilitate, specialist publication and scientific services group Fishawack Indicia and US-based JK Associates.

Oliver Dennis, chief executive officer, Fishawack Group, said: “This acquisition is a major step in Fishawack’s plan to build a global strategic creative agency that can work alongside our medical communications business.

“This is a great match and positions us to deliver integrated creative and medical communications solutions on a truly global scale.”

Article by
Gemma Jones

12th July 2018

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....